Access
To read this story in full you will need to login or make a payment (see right).
News
Nature Medicine 13, 6 (2007)
Published online: 28 December 2006 | doi:10.1038/nm0107-6b
Companies balk at California's patent rules for stem cell research
Brandon Keim1
- New York
Abstract
Other states could adopt similar strict policies.
California is set to adopt rules that will guarantee public return on its state-funded stem cell research, requiring grantees to share patented materials, send a portion of revenues to the state and guarantee cheap treatments to Californians.But the rules, which could set the tone for other state-funded science programs, are too restrictive and might put off companies, industry representatives warn.
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
